Genomic-based biomarkers of drug-induced nephrotoxicity

• HUANG Q, DUNN RT, JAYADEV S etal.: Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol. Sci. (2001) 63(2):196-207.
   PubMed Web of Science ®Google Scholar
• PETRICOIN EF 3rd, HACKETT JL, LESKO LJ etal.: Medical applications of microarray technologies: a regulatory science perspective. Nat. Genet. (2002) 32(Suppl.):474-479.
   PubMed Web of Science ®Google Scholar
• AMIN RP, VICKERS AE, SISTARE F etal.: Identification of putative gene based markers of renal toxicity. Environ. Health Perspect. (2004) 112(4):465-479.
   PubMed Web of Science ®Google Scholar
• KRAMER JA, PETTIT SD, AMIN RP etal.: Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ. Health Perspect. (2004) 112(4):460-464.
   PubMed Web of Science ®Google Scholar
• SEARFOSS GH, JORDAN WH, CALLIGARO DO etal.: Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J. Biol. Chem. (2003) 278(46):46107-46116.
   PubMed Web of Science ®Google Scholar
• GOODSAID FM: Genomic biomarkers of toxicity. Curr. Opin. Drug Discov. Devel. (2003) 6(1):41-49.
   PubMed Web of Science ®Google Scholar
• HAMADEH HK, KNIGHT BL, HAUGEN AC etal.: Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol. Pathol. (2002) 30(4):470-482.
   PubMed Web of Science ®Google Scholar
• THUKRAL SK, NORDONE PJ, HU R etal.: Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol. (2005) 33(3):343-355.
   PubMed Web of Science ®Google Scholar
• BARTOSIEWICZ MJ, JENKINS D, PENN S, EMERY J, BUCKPITT A: Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J. Pharmacol. Exp. Ther. (2001) 297(3):895-905.
   PubMed Web of Science ®Google Scholar
• THOMAS RS, RANK DR, PENN SG etal.: Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. (2001) 60(6):1189-1194.
   PubMed Web of Science ®Google Scholar
• HAMADEH HK, BUSHEL PR, JAYADEV S etal.: Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. (2002) 67(2):219-231.
   PubMed Web of Science ®Google Scholar
• SARTOR M, SCHWANEKAMP J, HALBLEIB D etal.: Microarray results improve significantly as hybridization approaches equilibrium. Biotechniques (2004) 36(5):790-796.
   PubMed Web of Science ®Google Scholar
• WERNER M, COSTA MJ, MITCHELLLG, NAYAR R: Nephrotoxicity of xenobiotics. Clin. Chim. Acta (1995) 237(1-2):107-154.
   PubMed Web of Science ®Google Scholar
• KHAN KNAA CL: Kidney. In: Handbook of Toxicological Pathology. WM Haschek, CG Rousseaux, MA Wallig (Eds), Academic Press, San Diego, US (2002):255-336.
   Google Scholar
• LOEB WF: The measurement of renal injury. Toxicol. Pathol. (1998) 26(1):26-28.
   PubMed Web of Science ®Google Scholar
• STAR RA: Treatment of acute renal failure. Kidney Int. (1998) 54(6):1817-1831.
   PubMed Web of Science ®Google Scholar
• HAN WK, BAILLY V, ABICHANDANIR, THADHANI R, BONVENTRE JV: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. (2002) 62(1):237-244.
   PubMed Web of Science ®Google Scholar
• CHARLWOOD J, SKEHEL JM, KING N etal.: Proteomic analysis of rat kidney cortex following treatment with gentamicin. J. Proteome. Res. (2002) 1(1):73-82.
   PubMed Web of Science ®Google Scholar
• AICHER L, WAHL D, ARCE A, GRENET O, STEINER S: New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis (1998) 19(11):1998-2003.
   PubMed Web of Science ®Google Scholar
• PRICE RG, TAYLOR SA, CHIVERS I etal.: Development and validation of new screening tests for nephrotoxic effects. Hum. Exp. Toxicol. (1996) 15(Suppl. 1):S10-S19.
   PubMed Web of Science ®Google Scholar
• HOUGHTON DC, LEE D, GILBERTDN, BENNETT WM: Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration function. Am. J. Pathol. (1986) 123(1):183-194.
   PubMed Web of Science ®Google Scholar
• MINGEOT-LECLERCQ MP, TULKENSPM: Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. (1999) 43(5):1003-1012.
   PubMed Web of Science ®Google Scholar
• THOMPSON KL, AFSHARI CA, AMINRP etal.: Identification of platform-independent gene expression markers of cisplatin nephrotoxicity. Environ. Health Perspect. (2004) 112(4):488-494.
   PubMed Web of Science ®Google Scholar
• SAFIRSTEIN RL: Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int. Suppl. (2004) 91:S62-S66.
   PubMedGoogle Scholar
• YOSHIDA T, KURELLA M, BEATO F etal.: Monitoring changes in gene expression in renal ischemiareperfusion in the rat. Kidney Int. (2002) 61(5):1646-1654.
   PubMed Web of Science ®Google Scholar
• NAHM O, WOO SK, HANDLER JS, KWON HM: Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am. J. Physiol. Cell. Physiol. (2002) 282(1):C49-C58.
   PubMed Web of Science ®Google Scholar
• LUHE A, HILDEBRAND H, BACH U, DINGERMANN T, AHR HJ: A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling invivo and invitro employing cDNA microarrays. Toxicol. Sci. (2003) 73(2):315-328.
   PubMed Web of Science ®Google Scholar
• WALKER R: Risk assessment of ochratoxin: current views of the European Scientific Committee on Food, the JECFA and the Codex Committee on Food Additives and Contaminants. Adv. Exp. Med. Biol. (2002) 504:249-255.
   PubMed Web of Science ®Google Scholar
• DAVIS JW 2nd, GOODSAID FM, BRALCM etal.: Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicol. Appl. Pharmacol. (2004) 200(1):16-26.
   PubMed Web of Science ®Google Scholar
• BAILLY V, ZHANG Z, MEIER W etal.: Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. (2002) 277(42):39739-39748.
   PubMed Web of Science ®Google Scholar
• ETI S, CHENG CY, MARSHALL A, REIDENBERG MM: Urinary clusterin in chronic nephrotoxicity in the rat. Proc. Soc. Exp. Biol. Med. (1993) 202(4):487-490.
   PubMed Web of Science ®Google Scholar
• ROSENBERG ME, SILKENSEN J: Clusterin and the kidney. Exp. Nephrol. (1995) 3(1):9-14.
   PubMedGoogle Scholar
• VICKERS AE, ROSE K, FISHER R etal.: Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology. Toxicol. Pathol. (2004) 32(5):577-590.
   PubMed Web of Science ®Google Scholar
• STORCK T, VON BREVERN MC, BEHRENS CK, SCHEEL J, BACH A: Transcriptomics in predictive toxicology. Curr. Opin. Drug Discov. Devel. (2002) 5(1):90-97.
   PubMed Web of Science ®Google Scholar
• LINDON JC, NICHOLSON JK, HOLMES E etal.: Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. (2003) 187(3):137-146.
   PubMed Web of Science ®Google Scholar
• KOOP R: Combinatorial biomarkers: from early toxicology assays to patient population profiling. Drug Discov. Today (2005) 10(11):781-788.
   PubMed Web of Science ®Google Scholar

Websites

• http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html Challenge and opportunity on the critical path to new medical products.
   Google Scholar
• http://www.fda.gov/cder/guidance/6400fnl.pdf Guidance forindustry: pharmacogenomic data submissions.
   Google Scholar
• http://www.ensembl.org/index.html
   Google Scholar
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=genomeprj
   Google Scholar